NCCM
IDXX icon

Nine Chapters Capital Management’s Idexx Laboratories IDXX Stock Holding History

Nine Chapters Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-13,800
Closed -$813K – 1049
2014
Q3 		$813K Buy
+13,800
New +$873K 0.07% 364

Other funds holding IDXX

RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nine Chapters Capital Management's IDXX Position: Q4 2014 in Review

Nine Chapters Capital Management sold out of Idexx Laboratories (IDXX) in Q4 2014, closing a stake of 13,800 shares — an estimated $813K sold.

Nine Chapters Capital Management first reported a position in IDXX in Q3 2014 and held it in 1 quarter. The position peaked at $813K in Q3 2014. 352 funds tracked by Wall St. Rank hold IDXX as of Q4 2014.

  • Nine Chapters Capital Management reported no remaining Idexx Laboratories position as of Q4 2014 after selling out during the quarter.
  • Nine Chapters Capital Management sold 13,800 Idexx Laboratories shares in Q4 2014, an estimated $813K.
  • Nine Chapters Capital Management first reported a position in Idexx Laboratories in Q3 2014 and held it in 1 quarter.
  • Nine Chapters Capital Management's Idexx Laboratories position peaked at $813K in Q3 2014.
  • 352 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2014.

Based on Nine Chapters Capital Management's 13F filing for Q4 2014, filed 9 Feb 2015.